Merck today announced that it has signed a license agreement providing Evotec SE access to Merck’s foundational CRISPR intellectual property. DARMSTADT, GERMANY License to accelerate research, enable testing and development of new drugs Merck, a leading science and technology company, today announced that it has signed a license agreement providing Evotec SE access to Merck’s foundational CRISPR […]
Leading immuno-oncology company adopts Genedata Biologics to support the discovery and development of TCRs for adoptive cell therapies and bispecific TCR molecules Basel, Switzerland Genedata, the leading provider of enterprise software solutions for biopharmaceutical R&D, today announced that Immatics Biotechnologies, a clinical-stage biopharmaceutical company developing T-cell receptor (TCR)-based cancer immunotherapies, has adopted Genedata Biologics® to streamline their R&D […]
Nanopore sequencing can now be used for investigating chromatin contacts, to identify genome-wide contacts directly, without amplification. Weill Cornell Medicine and Oxford Nanopore have published a pre-print describing this new technique, and an end-to-end workflow and analysis tools are now available online. Investigating genome architecture Chromatin structure relies on the physical interaction of many genomic loci and investigating the architecture of […]
To mark the recent launch of Edinburgh Instruments new RM5 Raman Microscope, the company has today announced its partnership with Bio-Rad and its KnowItAll Raman Spectral Identification Partner Program. The partnership enables Edinburgh Instruments to give its customers access to the largest Raman Spectral Database and Raman Identification Software. As a Bio-Rad Raman Spectral Identification Partner, […]
BrickBio’s technology enables efficient placement of unnatural amino acids into recombinant antibodies at specific sites Together, the organizations will industrialize the technology to serve both the research and diagnostic markets CAMBRIDGE, UK and BOSTON, MA, USA — Abcam plc, a global innovator in life science reagents and tools, is today pleased to announce a strategic partnership […]
Twist Biopharma Implements Genedata Biologics to Advance Synthetic Biology-driven Antibody Discovery
First-in-class software platform digitalizes Twist Biopharma’s innovative antibody lead identification and optimization SAN FRANCISCO–Genedata, the leading provider of enterprise software solutions for biopharmaceutical R&D, today announced that Twist Biopharma, a division of Twist Bioscience (NASDAQ: TWST), has adopted Genedata Biologics® to support their R&D innovation for biologics drug discovery services. In addition, Twist will use the […]
SHENZHEN, China — The “Million Microbiome of Humans Project” (MMHP) was officially launched at the 14th International Conference on Genomics (ICG-14). Scientistsfrom China, Sweden, Denmark, France, Latvia and other countries will cooperate in microbial metagenomic research, aiming to sequence and analyze one million microbial samples from intestines, mouth, skin, reproductive tract and other organs in the next three to five years to […]
SEOUL, South Korea–prismCDX, a highly specialized contract research organization announced today the selection and adoption of the UltiMapper platform to broaden its offering of translational biomedical research services. The addition of Ultivue’s highly standardized multiplex tissue marker assays enables the identification of critical cellular phenotypes and tissue marker signatures in support of translational and clinical […]
Kassel, Germany and Cambridge, MA – Targos Molecular Pathology GmbH, a market leader in clinical biomarker services announced today a technology partnership with Ultivue, the innovation leader in multiplex tissue biomarker assays, to offer the biopharmaceutical industry new capabilities to improve the characterization of cancer patients’ samples selected for clinical research programs. UltiMapper multiplex immuno-histochemistry […]
Genedata Selector® deployed to streamline complex cell line development processes Basel, Switzerland – Genedata, the leading provider of enterprise software solutions for biopharmaceutical R&D, today announced an expansion of its collaboration with Boehringer Ingelheim, a research-driven pharmaceutical company, to digitalize and automate complex cell line development processes. As part of this collaboration, Genedata Selector has been deployed […]
Pay Invoice
Latest Blogs
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
